ArticleJournal of translational medicine2023

Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.

Antonio Agostini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.